Search

Hutchison China MediTech Ltd ADR

Fechado

SetorSaúde

12.49 -1.03

Visão Geral

Variação de preço das ações

24h

Atual

Mín

11.76

Máximo

12.54

Indicadores-chave

By Trading Economics

Rendimento

-8.9M

-8M

Vendas

3.7M

139M

P/E

Médio do Setor

125.6

57.371

Margem de lucro

-5.724

Funcionários

1,790

EBITDA

18M

4M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+14.95% upside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

271M

2.2B

Abertura anterior

13.52

Fecho anterior

12.49

Sentimento de Notícias

By Acuity

100%

0%

326 / 340 Ranking em Healthcare

Hutchison China MediTech Ltd ADR Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

19 de ago. de 2026, 23:56 UTC

News

Wayfair shares rise in after-market hours after Rosenblatt analyst Scott Devitt initiated coverage with a Buy rating and a price target of $125.00.

19 de ago. de 2026, 23:56 UTC

News
Social Media

Cogent Communications is facing a class action lawsuit over alleged false statements, contributing to a decline in shares during after-market hours.

19 de ago. de 2026, 23:52 UTC

News
Correlated Moves

Cohen & Steers Inc. shares are lower in after-market trading, continuing a trend of five consecutive daily declines. The fund declared a monthly dividend of $0.126 per share.

19 de ago. de 2026, 23:51 UTC

News

Biomarin Pharmaceutical Inc shares are lower in after-market hours amid a broader Biotechnology sector decline, despite a recent $275 million acquisition of Alesta Therapeutics.

19 de ago. de 2026, 23:51 UTC

News
Social Media

Ultragenyx Pharmaceutical received FDA accelerated approval for its gene therapy GENGLYCOS, leading shares to rise sharply in after-market hours.

19 de ago. de 2026, 23:41 UTC

News

Target Corp shares are lower in after-market hours despite stronger-than-expected second-quarter earnings of $4.11 per share and a raised full-year forecast.

19 de ago. de 2026, 23:36 UTC

News
Social Media

Rosenblatt analyst Scott Devitt initiated coverage on Amazon.com with a Buy rating. Shares advanced in after-market trading following this positive assessment.

19 de ago. de 2026, 23:31 UTC

News

Wendy's Co shares are lower in after-market hours following a management reset and reports of Trian Fund Management exploring a potential buyout.

19 de ago. de 2026, 23:26 UTC

News

Constellation Brands announced a $100 million investment over five years to support farmers in Idaho, Montana, and North Dakota. Shares were roughly flat in after-market trading.

19 de ago. de 2026, 23:22 UTC

News
Social Media
Correlated Moves

Coinbase Global Inc shares are higher in after-market trading amid bullish social media sentiment and the announcement of direct USDC trading in Brazil.

19 de ago. de 2026, 23:21 UTC

Social Media
Correlated Moves
News

Marvell Technology shares rise in after-hours trading following a significant deal with Google, which includes a warrant for 58.97 million shares at $206.58 each.

19 de ago. de 2026, 23:21 UTC

Correlated Moves
News

Microstrategy Inc. shares rose in after-market trading, driven by increased bullish options activity and positive remarks on its Bitcoin strategy from executives.

19 de ago. de 2026, 23:21 UTC

News

Kratos Defense shares are rising in after-market trading as the U.S. Air Force evaluates alternatives to existing aerial targets, including the BQM-167A.

19 de ago. de 2026, 23:21 UTC

Event
Social Media
News

BILL Holdings reported strong Q4 results, with adjusted net income of $94 million. Shares are higher in after-hours trading following the earnings report.

19 de ago. de 2026, 23:16 UTC

News

Accuray Inc shares fell in after-market hours following a net loss of $1.94 million and revenue of $100.92 million, missing expectations.

19 de ago. de 2026, 23:16 UTC

News
Social Media

Iovance Biotherapeutics shares reached a new 52-week high amid positive melanoma treatment sector sentiment and an anticipated revenue guidance increase.

19 de ago. de 2026, 23:16 UTC

News
Social Media

Netflix Inc. is trading higher in after-market hours amid reports of competitive strategies in the streaming industry, including YouTube's incentives for exclusive content.

19 de ago. de 2026, 23:11 UTC

News

Carlyle Group invests in Castelion's $1 billion funding round, boosting defense sector engagement. Shares are higher in after-market trading following the announcement.

19 de ago. de 2026, 23:11 UTC

News

Northrop Grumman declared a quarterly dividend of $2.47 per share, contributing to shares trading higher in after-market hours.

19 de ago. de 2026, 23:11 UTC

Correlated Moves
News

The Australian Dollar is gaining against the Hong Kong Dollar amid rising global bond yields and inflation concerns linked to geopolitical tensions.

19 de ago. de 2026, 23:06 UTC

News

Replimune Group shares declined in after-market hours following the grant of equity awards to Chief Commercial Officer Michelle DiNapoli, raising potential dilution concerns.

19 de ago. de 2026, 23:06 UTC

News

Ionis Pharmaceuticals is advancing RG-6299 into a pivotal Phase III trial for IgA nephropathy in collaboration with Roche and Chugai. Shares are higher in after-market trading.

19 de ago. de 2026, 23:06 UTC

Social Media
News

Hims & Hers Health Inc. shares are lower in after-market trading following a lawsuit from the FTC alleging deceptive practices regarding user privacy and billing.

19 de ago. de 2026, 23:06 UTC

News

Chewy Inc shares are lower in after-market trading as cautious sentiment grows ahead of the September earnings call and a Neutral rating from Rosenblatt.

19 de ago. de 2026, 23:06 UTC

News
Correlated Moves

Geopolitical tensions and Fed concerns contribute to a decline in the iShares 20+ Year Treasury Bond ETF in after-market trading. The iShares TIPS Bond ETF also moves lower.

19 de ago. de 2026, 23:06 UTC

Social Media
News

SPDR Gold Shares trade higher after-market, boosted by social media discussions on its return above the 200-day moving average amid geopolitical tensions and inflation concerns.

19 de ago. de 2026, 23:06 UTC

News
Correlated Moves

Geopolitical tensions and inflation concerns support iShares Silver Trust's gains during after-market hours, maintaining a position above its 20-day moving average.

19 de ago. de 2026, 23:06 UTC

Correlated Moves
News

Northern Oil and Gas announced a $500 million senior notes offering, contributing to a decline in shares during after-market trading. EOG also fell amid sector dynamics.

19 de ago. de 2026, 23:06 UTC

News
Correlated Moves

Twist Bioscience Corp shares are lower in after-market hours following a critical short report from Scorpion Capital questioning the company's AI-driven protein design strategy.

19 de ago. de 2026, 23:02 UTC

News

Encore Capital Group appoints Robert Beck to its board, effective immediately. The move has contributed to shares rising in after-market trading.

Comparação entre Pares

Variação de preço

Hutchison China MediTech Ltd ADR Previsão

Preço-alvo

By TipRanks

14.95% parte superior

Previsão para 12 meses

Média 14.53 USD  14.95%

Máximo 16 USD

Mínimo 13.6 USD

Com base em 3 analistas de Wall Street que oferecem metas de preço de 12 meses para Hutchison China MediTech Ltd ADR - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

3 ratings

1

Comprar

2

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Hutchison China MediTech Ltd ADR

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors. It also develops Surufatinib, which is used for the treatment of pancreatic neuroendocrine tumor (NET), non-pancreatic NET, neuroendocrine carcinoma, SCLC, biliary tract cancer, and solid tumors; and Sovleplenib that treats hematological cancers and certain chronic immune diseases. In addition, it develops Tazemetostat for the treatment of certain epithelioid sarcoma and follicular lymphoma patients; HMPL-306, an inhibitor for hematological malignancies, gliomas, chondrosarcomas, cholangiocarcinomas, and solid tumors; HMPL-760, a Bruton's tyrosine kinase inhibitor; HMPL-453 for intrahepatic cholangiocarcinoma and solid tumors; HMPL-295 and HMPL-415 for solid tumors; HMPL-653 for metastatic solid tumors and tenosynovial giant cell tumors; and HMPL-A83 for the treatment of malignant neoplasms. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, Takeda, BeiGene Ltd., Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., Genor Biopharma Co. Ltd., Shanghai Junshi Biosciences Co. Ltd., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Hong Kong, Hong Kong.
help-icon Live chat